Making cognitive screening easy for primary care providers
Official title: Cognitive Screening Made Easy for PCPs - Administrative Supplement
Run by University of Texas at Austin · NCT06928298 · Data updated 2026-11-12
This project will test an automated Spanish‑language risk assessment and brief iPad cognitive screen to help primary care teams find early memory and thinking problems in people aged 60 and older.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Texas at Austin Academic / other |
| Locations | 3 sites (Austin, Texas and 2 other locations) |
| Status | Recruiting |
| Started | June 10, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | April 30, 2027 |
| Registry record updated | February 5, 2026 |
| Trial ID | NCT06928298 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Spanish‑fluent adults aged 60 or older without a prior dementia diagnosis who can independently use an iPad and attend participating UT clinics in Texas.
✕Probably not a fit
People with a prior dementia diagnosis, significant motor or visual impairments that prevent independent iPad use, or who are not Spanish‑fluent are unlikely to benefit from this project.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project develops and implements an automated risk assessment and brief cognitive screening app (RACS) tailored for use in primary care settings. The tool is designed to minimize time and effort for clinicians or staff while remaining sensitive to cognitive decline across diverse educational and racial/ethnic backgrounds. The study will enroll Spanish‑fluent adults aged 60+ without a prior dementia diagnosis who can use an iPad and will be conducted at several UT‑affiliated primary care and geriatric clinics in Texas. Key outcomes include feasibility, screening rates, and identification of cognitive impairment during routine visits.
Why it matters
Potential benefit: If successful, the tool could help primary care teams detect cognitive decline earlier so patients can get treatment, support, and planning sooner.
How similar studies have gone: Brief cognitive screening programs in primary care have improved detection rates, but fully automated Spanish‑language tools like this have been less widely tested in real-world clinics.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Inclusion Criteria: * Aged 60 years and older; * Ethnic/racial background consistent with NIH policy * Male or female * Fluent in Spanish. Exclusion Criteria: * Confounding conditions that could impact ability to participate in the study (e.g., cognitive impairment sufficient to impact ability to follow instructions on the iPad, motor impairment that would prohibit independent use of RACS, poor visual acuity) * Prior diagnosis of dementia * Non-Spanish speaking.
Where it's running
-
Family Wellness Clinic
Austin, Texas, United States Recruiting -
University of Texas Health Austin Primary Care Clinic
Austin, Texas, United States Recruiting -
UT Health San Antonio's Geriatrics and Supportive Care Clinic
San Antonio, Texas, United States Recruiting
Study contacts
- Principal investigator: Robin C Hilsabeck, PhD — University of Texas Health Sciences Center at San Antonio
- Study coordinator: Robin C Hilsabeck, PhD
- Email: hilsabeck@uthscsa.edu
- Phone: 210-835-8748
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Accelerated rTMS for Cognitive Function in adults with mild to moderate cognitive impairment
This study tests whether a short course of accelerated rTMS with the EXOMIND device can improve thinking skills in adults ages 50–90 with mild cognitive impairment or mild dementia.
-
Cognitive screening and multidomain care to slow memory and thinking decline in older adults with type 2 diabetes
This study will test whether regular cognitive screening plus a two-year program of medication optimization, adjusted HbA1c targets, vascular risk management, lifestyle changes, and social support can slow cognitive decline in people aged 65 and older with type 2 diabetes.
-
Memantine plus structured exercise to protect thinking and memory during breast cancer chemotherapy
This will test whether memantine combined with a supervised exercise program, memantine alone, or a placebo can prevent or reduce thinking and memory problems in people receiving chemotherapy for stage I–III breast cancer.
-
Effects of different anesthesia techniques on cognitive function in elderly hip fracture patients
This study tests different anesthesia methods to see which one helps older patients with hip fractures keep their thinking skills sharp during and after surgery.
-
Combining sleep promotion and cognitive training to improve brain function in older ICU survivors
This study is testing if helping older adults who survived ICU treatment sleep better and do brain exercises can improve their thinking skills.
-
Impact of Dietary Fats on Cognitive Function
This study tests whether eating walnuts or a dairy-free chocolate bar can improve thinking and memory in adults who feel their brain isn't working as well as it used to.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.